Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
Research output: Contribution to journal › Journal article › Research › peer-review
Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.
| Original language | English |
|---|---|
| Journal | Journal of Thrombosis and Haemostasis |
| Volume | 9 |
| Issue number | 8 |
| Pages (from-to) | 1460-7 |
| Number of pages | 8 |
| ISSN | 1538-7933 |
| DOIs | |
| Publication status | Published - 1 Aug 2011 |
ID: 40155679